<< 1 2 3 4 5  ... >> 

Exosomes Possible Biomarker for Targeted Sarcoma Therapy
Published: 3/9/2018

Researchers at The University of Kansas Cancer Center are studying tiny vesicles that may help lead to more targeted cancer therapies. Also called exosomes, these microvesicles act as “fingerprints” of a tumor’s identity, providing early clues to cancer cases.

First Patient Dosed with Ciclopirox Prodrug in Phase I Trial in Patients with Advanced Solid Tumors
Published: 3/1/2018

CicloMed LLC, a biotechnology company developing novel treatments for bladder cancer, announced that the first patient has been dosed in a Phase I clinical trial.

Scott Weir Named Research Recipient of 2018 Global Health Repurposing Awards
Published: 2/27/2018

Scott Weir, Pharm.D., Ph.D., of The University of Kansas Cancer Center, is the recipient of the 2018 Janet Davison Rowley Patient Impact Research Award.

KU Cancer Center named “High-Performing Site” by National Cancer Institute
Published: 2/9/2018

The University of Kansas Cancer Center was recently recognized as a “high-performing site” by the National Cancer Institute (NCI).

Researchers receive grant to study use of natural compounds in triple-negative breast cancer prevention
Published: 10/31/2017

Researchers at The University of Kansas Cancer Center will explore triple-negative breast cancer prevention therapies using natural compounds thanks to a grant for approximately $1.5 million in funding by the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP).

<< 1 2 3 4 5  ... >> 


Browse by Year
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Expert Care

find a doctor

Named Among US News & World Reports Best Hospitals for Cancer care 2017-18

Request an Appointment